SoFi Technologies, Inc. SOFI will report its first-quarter 2026 results on April 29, before the bell. The Zacks Consensus ...
BioMarin Pharmaceutical has completed its $4.8 billion acquisition of Amicus Therapeutics, adding therapies for Fabry and Pompe diseases and a Phase III kidney disorder candidate. The move enhances ...
The chart patterns identified are based on established principles of technical analysis and are presented solely for informational purposes. These should not be misconstrued as a recommendation to buy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results